Print

New ANDA Cases

Case Name Date Filed Judge Drug Patent No(s).
Purdue Pharma L.P. v. Alvogen Pine Brook, LLC, 17-1369 (D. Del.) Oct. 2, 2017 Hon. Gregory M. Sleet Hysingla® ER (hydrocodone bitartrate extended-release tablets)
9,750,703
9,763,933
9,770,416
9,775,809
Boehringer Ingelheim Pharms., Inc. v. Aurobindo Pharma USA Inc., 17-7887 (D.N.J.) Oct. 4, 2017 Hon. Michael A. Shipp Gilotrif® (afatinib dimaleate tablets) 8,426,586
Forest Labs. Holdings, Ltd. v. Strides Pharma Global PTE Ltd., 17-1394 (D. Del.) Oct. 5, 2017 Hon. Gregory M. Sleet Savella® (milnacipran HCl tablets)
6,602,911
7,888,342
7,994,220
Boehringer Ingelheim Pharms., Inc. v. Hetero USA Inc., 17-7923 (D.N.J.) Oct. 5, 2017 Hon. Michael A. Shipp Gilotrif® (afatinib dimaleate tablets) 8,426,586
Purdue Pharma L.P. v. Collegium Pharm., Inc., 17-cv-11923 (D. Mass.) Oct. 6, 2017 Hon. F. Dennis Saylor, IV Xtampza® ER (oxycodone extended-release capsules)XXOxyContin® (oxycodone HCl extended-release tablets)
9,522,919
9,073,933
Forest Labs. Holdings, Ltd. v. Strides Pharma Global PTE Ltd., 17-7996 (D.N.J.) Oct. 6, 2017 Hon. Brian R. Martinotti Savella® (milnacipran HCl tablets)
6,602,911
7,888,342
7,994,220
Indivior Inc. v. Par Pharm., Inc., 17-7997 (D.N.J.) Oct. 6, 2017 Hon. Kevin McNulty Suboxone® (buprenorphine HCl / naloxone HCl sublingual film) 9,687,454
Insys Therapeutics, Inc. v. Alkem Labs. Ltd., 17-1419 (D. Del.) Oct. 10, 2017 Hon. Leonard P. Stark Syndros® (dronabinol oral solution)
8,222,292
9,345,771
Purdue Pharma L.P. v. Amneal Pharms., LLC, LLC 17-1421 (D. Del.) Oct. 10, 2017 Hon. Richard G. Andrews OxyContin® (oxycodone HCl extended-release tablets)
9,763,886
9,763,933
9,675,610
Noven Pharms., Inc. v. Alvogen Pine Brook LLC, 17-1429 (D. Del.) Oct. 11, 2017 Hon. Leonard P. Stark Minivelle® (estradiol transdermal system)
9,730,900
9,724,310
Amarin Pharma, Inc. v. Teva Pharms. USA, Inc., 17-2641 (D. Nev.) Oct. 11, 2017 Hon. Miranda M. Du Vascepa® (icosapent ethyl capsules)
8,293,728
8,318,715
8,357,677
8,367,652
8,377,920
8,415,335
8,426,399
8,440,650
8,518,929
8,524,698
8,546,372
8,617,594
Hoffmann-La Roche Inc. v. Airis Pharma Private Ltd., 17-7912 (S.D.N.Y.) Oct. 13, 2017 Hon. Katherine B. Forrest Valcyte® (valganciclovir HCl oral solution)
9,642,911
8,889,109
Boehringer Ingelheim Pharms., Inc. v. MSN Labs. Private Ltd., 17-8399 (D.N.J.) Oct. 16, 2017 Hon. Michael A. Shipp Gilotrif® (afatinib dimaleate tablets) 8,426,586
Sawai USA, Inc. v. Astellas Pharma Inc., IPR2018-00079 (PTAB) Oct. 16, 2017 N/A Myrbetriq® (mirabegron extended-release tablets) 6,346,532
Takeda Pharms. U.S.A., Inc. v. Macleods Pharms. Ltd., 17-1469 (D. Del.) Oct. 17, 2017 Hon. Richard G. Andrews Colcrys® (colchicine tablets)
7,906,519
7,935,731
8,093,298
7,964,648
8,093,297
7,619,004
7,601,758
7,820,681
7,915,269
7,964,647
7,981,938
8,093,296
8,097,655
8,415,395
8,415,396
8,440,721
8,440,722
Acrux DDS Pty Ltd. v. Sandoz, Inc., 17-3824 (S.D. Ind.) Oct. 23, 2017 Hon. Sarah Evans Barker Axiron® (testosterone topical solution)
8,435,944
8,993,520
9,180,194
Bristol-Myers Squibb Co. v. Apotex Inc., 17-1493 (D. Del.) Oct. 24, 2017 Hon. Leonard P. Stark Reyataz® (atazanavir sulfate capsules) 6,087,383
Sanofi-Aventis U.S. LLC v. Mylan N.V., 17-9105 (D.N.J.) Oct. 24, 2017 Hon. Stanley R. Chesler Lantus® (insulin glargine injection)XXLantus® SoloSTAR® (insulin glargine injection)
7,476,652
7,713,930
7,918,833
8,512,297
8,556,864
8,603,044
8,679,069
8,992,486
9,011,391
9,233,211
9,408,979
9,526,844
9,533,105
9,561,331
9,604,008
9,604,009
9,610,409
9,623,189
Acrux DDS Pty Ltd. v. Sandoz, Inc., 17-2558 (D. Col.) Oct. 25, 2017 Hon. Nina Y. Wang Axiron® (testosterone topical solution)
8,435,944
8,993,520
9,180,194
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. v. Gilead Pharmasset LLC, IPR2018-00119 (PTAB) Oct. 25, 2017 N/A Sovaldi® (sofosbuvir tablets)XXHarvoni® (ledipasvir / sofosbuvir tablets)XXEpclusa® (sofosbuvir / velpatasvir tablets)XXVosevi® (sofosbuvir / velpatasvir / voxilaprevir tablets) 7,964,580
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. v. Gilead Pharmasset LLC, IPR2018-00120 (PTAB) Oct. 25, 2017 N/A Sovaldi® (sofosbuvir tablets)XXHarvoni® (ledipasvir / sofosbuvir tablets)XXEpclusa® (sofosbuvir / velpatasvir tablets)XXVosevi® (sofosbuvir / velpatasvir / voxilaprevir tablets) 7,964,580
Sanofi-Aventis U.S. LLC v. Mylan N.V., 17-0181 (N.D.W.V.) Oct. 26, 2017 Hon. Irene M. Keeley Lantus® (insulin glargine injection)XXLantus® SoloSTAR® (insulin glargine injection)
7,476,652
7,713,930
7,918,833
8,512,297
8,556,864
8,603,044
8,679,069
8,992,486
9,011,391
9,233,211
9,408,979
9,526,844
9,533,105
9,561,331
9,604,008
9,604,009
9,610,409
9,623,189
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. v. Gilead Pharmasset LLC, IPR2018-00121 (PTAB) Oct. 26, 2017 N/A Sovaldi® (sofosbuvir tablets)XXHarvoni® (ledipasvir / sofosbuvir tablets)XXEpclusa® (sofosbuvir / velpatasvir tablets)XXVosevi® (sofosbuvir / velpatasvir / voxilaprevir tablets) 8,334,270
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. v. Gilead Pharmasset LLC, IPR2018-00122 (PTAB) Oct. 26, 2017 N/A Sovaldi® (sofosbuvir tablets)XXHarvoni® (ledipasvir / sofosbuvir tablets)XXEpclusa® (sofosbuvir / velpatasvir tablets)XXVosevi® (sofosbuvir / velpatasvir / voxilaprevir tablets) 8,334,270
Pfizer Inc. v. Breckenridge Pharm., Inc., 17-1532 (D. Del.) Oct. 30, 2017 Hon. Leonard P. Stark Xeljanz® (tofacitinib tablets)
6,956,041
7,091,208
7,265,221
RE41,783
Recro Gainesville LLC v. Actavis Labs. FL, Inc., 17-1535 (D. Del.) Oct. 30, 2017 Hon. Gregory M. Sleet Zohydro® (hydrocodone bitartrate extended-release capsules) 9,713,611
Allergan Sales, LLC v. Sandoz, Inc., 17-10129 (D.N.J.) Oct. 30, 2017 Hon. William H. Walls Combigan® (brimonidine tartrate / timolol maleate ophthalmic solution) 9,770,453
Forest Labs., LLC v. MSN Labs. Private Ltd., 17-10140 (D.N.J.) Oct. 30, 2017 Hon. Esther Salas Fetzima® (levomilnacipran HCl extended-release capsules)
8,481,598
8,865,937
RE43,879
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. v. Gilead Pharmasset LLC, IPR2018-00125 (PTAB) Oct. 30, 2017 N/A Sovaldi® (sofosbuvir tablets)XXHarvoni® (ledipasvir / sofosbuvir tablets)XXEpclusa® (sofosbuvir / velpatasvir tablets)XXVosevi® (sofosbuvir / velpatasvir / voxilaprevir tablets) 8,633,309
Pfizer Inc. v. Umedica Labs. Pvt., Ltd., 17-1551 (D. Del.) Oct. 31, 2017 Hon. Richard G. Andrews Viagra® (sildenafil citrate tablets) 6,469,012
iCeutica Pty Ltd v. Apotex, Inc., 17-1553 (D. Del.) Oct. 31, 2017 Vacant Judgeship (2017) Zorvolex® (diclofenac capsules)
8,679,544
8,999,387
9,017,721
9,173,854
9,180,095
9,180,096
9,186,328
iCeutica Pty Ltd v. Apotex Inc., 17-1554 (D. Del.) Oct. 31, 2017 Vacant Judgeship (2017) Vivlodex® (meloxicam capsules)
9,526,734
9,649,318
Forest Labs., LLC v. Prinston Pharm Inc., 17-10230 (D.N.J.) Oct. 31, 2017 Hon. Esther Salas Fetzima® (levomilnacipran HCl extended-release capsules)
8,481,598
8,865,937
RE43,879
Forest Labs., LLC v. Torrent Pharms. Ltd., 17-10273 (D.N.J.) Oct. 31, 2017 Hon. Esther Salas Fetzima® (levomilnacipran HCl extended-release capsules)
8,481,598
8,865,937
RE43,879
Forest Labs., LLC v. Westward Pharms. Int'l Ltd., 17-10321 (D.N.J.) Oct. 31, 2017 Hon. Esther Salas Fetzima® (levomilnacipran HCl extended-release capsules)
8,481,598
8,865,937
RE43,879
Forest Labs., LLC v. Zydus Pharms. (USA) Inc., 17-10330 (D.N.J.) Oct. 31, 2017 Hon. Esther Salas Fetzima® (levomilnacipran HCl extended-release capsules)
8,481,598
8,865,937
RE43,879
Hospira, Inc. v. Presenius Kabi USA, LLC, 17-7903 (N.D. Ill.) Nov. 1, 2017 Hon. Rebecca R. Pallmeyer Precedex® (dexmedetomidine HCl injection) 9,616,049
ViiV Healthcare Co. v. Lupin Ltd., 17-1576 (D. Del.) Nov. 2, 2017 Vacant Judgeship (2017) Triumeq® (abacavir / dolutegravir / lamivudine tablets) 9,242,986
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. v. Gilead Pharmasset LLC, IPR2018-00126 (PTAB) Nov. 2, 2017 N/A Sovaldi® (sofosbuvir tablets)XXHarvoni® (ledipasvir / sofosbuvir tablets)XXEpclusa® (sofosbuvir / velpatasvir tablets)XXVosevi® (sofosbuvir / velpatasvir / voxilaprevir tablets) 9,284,342
Pfizer Inc. v. Sun Pharm. Indus. Ltd., 17-1597 (D. Del.) Nov. 7, 2017 Hon. Leonard P. Stark Xeljanz XR® (tofacitinib extended-release tablets) RE41,783
Mayne Pharma Int'l Pty Ltd. v. Actavis Elizabeth LLC, 17-1614 (D. Del.) Nov. 9, 2017 Vacant Judgeship (2017) Doryx® MPC (doxycycline hyclate delayed-release tablets)
6,958,161
9,295,652
9,446,057
9,511,031
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. v. Gilead Pharmasset LLC, IPR2018-00123 (PTAB) Nov. 9, 2017 N/A Harvoni® (ledipasvir / sofosbuvir tablets)XXEpclusa® (sofosbuvir / velpatasvir tablets)XXVosevi® (sofosbuvir / velpatasvir / voxilaprevir tablets) 8,735,372
Apotex Inc. v. Abraxis Bioscience, LLC, IPR2018-00151 (PTAB) Nov. 9, 2017 N/A Abraxane® (paclitaxel for injection) 8,138,229
Apotex Inc. v. Abraxis Bioscience, LLC, IPR2018-00152 (PTAB) Nov. 9, 2017 N/A Abraxane® (paclitaxel for injection) 7,820,788
Apotex Inc. v. Abraxis Bioscience, LLC, IPR2018-00153 (PTAB) Nov. 9, 2017 N/A Abraxane® (paclitaxel for injection) 7,923,536
Cipla Ltd. v. Abraxis Bioscience, LLC, IPR2018-00162 (PTAB) Nov. 9, 2017 N/A Abraxane® (paclitaxel for injection) 7,820,788
Cipla Ltd. v. Abraxis Bioscience, LLC, IPR2018-00163 (PTAB) Nov. 9, 2017 N/A Abraxane® (paclitaxel for injection) 7,923,536
Cipla Ltd. v. Abraxis Bioscience, LLC, IPR2018-00164 (PTAB) Nov. 9, 2017 N/A Abraxane® (paclitaxel for injection) 8,138,229
AbbVie Inc. v. Cipla Ltd., 17-1631 (D. Del.) Nov. 10, 2017 Hon. Richard G. Andrews Kaletra® (lopinavir / ritonavir tablets)
7,148,359
7,364,752
8,025,899
8,268,349
8,309,613
8,377,952
8,399,015
8,470,347
8,691,878
ViiV Healthcare Co. v. Apotex Inc., 17-1634 (D. Del.) Nov. 10, 2017 Vacant Judgeship (2017) Triumeq® (abacavir / dolutegravir / lamivudine tablets)XXTivicay® (dolutegravir tablets) 9,242,986
Boehringer Ingelheim Pharms., Inc. v. Teva Pharms. USA, Inc., 17-11510 (D.N.J.) Nov. 10, 2017 Hon. Michael A. Shipp Gilotrif® (afatinib tablets)
RE43,431
8,426,586
Mayne Pharma Int'l Pty Ltd. v. Lupin Ltd., 17-1637 (D. Del.) Nov. 13, 2017 Vacant Judgeship (2017) Doryx® MPC (doxycycline hyclate delayed-release tablets)
9,295,652
9,446,057
9,511,031
AstraZeneca LP v. Prinston Pharm. Inc., 17-1639 (D. Del.) Nov. 13, 2017 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets)
6,251,910
RE 46,276
7,250,419
7,265,124
Par Pharm., Inc. v. Indivior Inc., 17-1280 (E.D. Va.) Nov. 13, 2017 Hon. Claude M. Hilton Suboxone® (buprenorphine HCl / naloxone HCl sublingual film) 9,687,454
Delcor Asset Corp. v. Glenmark Pharms. Ltd., 17-1653 (D. Del.) Nov. 15, 2017 Hon. Richard G. Andrews Evoclin® (clindamycin phosphate aerosol, foam)
7,141,237
7,374,747
Forest Labs., LLC v. Aurobindo Pharma USA, Inc., 17-11679 (D.N.J.) Nov. 15, 2017 Hon. Esther Salas Fetzima® (levomilnacipran HCl extended-release capsules)
8,481,598
8,865,937
RE43,879
Forest Labs., LLC v. Amneal Pharms. LLC, 17-11680 (D.N.J.) Nov. 15, 2017 Hon. Esther Salas Fetzima® (levomilnacipran HCl extended-release capsules)
8,481,598
8,865,937
RE43,879
Eli Lilly and Co. v. Actavis LLC, 17-4299 (S.D. Ind.) Nov. 16, 2017 Hon. Tanya Walton Pratt Alimta® (pemetrexed for injection) 7,772,209
ViiV Healthcare Co. v. Cipla Ltd., 17-1670 (D. Del.) Nov. 17, 2017 Vacant Judgeship (2017) Triumeq® (abacavir / dolutegravir / lamivudine tablets) 9,242,986
ViiV Healthcare Co. v. Mylan Pharms. Inc., 17-1671 (D. Del.) Nov. 17, 2017 Vacant Judgeship (2017) Triumeq® (abacavir / dolutegravir / lamivudine tablets) 9,242,986
ViiV Healthcare Co. v. Mylan Pharms. Inc., 17-0197 (N.D.W.V.) Nov. 17, 2017 Hon. Irene M. Keeley Triumeq® (abacavir / dolutegravir / lamivudine tablets) 9,242,986
ViiV Healthcare Co. v. Dr. Reddy's Labs., Inc., 17-1678 (D. Del.) Nov. 20, 2017 Vacant Judgeship (2017) Triumeq® (abacavir / dolutegravir / lamivudine tablets) 9,242,986
ViiV Healthcare Co. v. Dr. Reddy's Labs., Inc., 17-11873 (D.N.J.) Nov. 20, 2017 Hon. Brian R. Martinotti Triumeq® (abacavir / dolutegravir / lamivudine tablets) 9,242,986
Takeda Pharms. U.S.A., Inc. v. Strides Pharma Global PTE Ltd., 17-1690 (D. Del.) Nov. 21, 2017 Hon. Richard G. Andrews Colcrys® (colchicine tablets)
7,906,519
7,935,731
8,093,298
7,964,648
8,093,297
7,619,004
7,601,758
7,820,681
7,915,269
7,964,647
7,981,938
8,093,296
8,097,655
8,415,395
8,415,396
8,440,721
8,440,722
Flatwing Pharms., LLC v. Anacor Pharms., Inc., IPR2018-00168 (PTAB) Nov. 21, 2017 N/A Kerydin® (tavaborole topical solution) 9,549,938
Flatwing Pharms., LLC v. Anacor Pharms., Inc., IPR2018-00169 (PTAB) Nov. 21, 2017 N/A Kerydin® (tavaborole topical solution) 9,566,289
Flatwing Pharms., LLC v. Anacor Pharms., Inc., IPR2018-00170 (PTAB) Nov. 21, 2017 N/A Kerydin® (tavaborole topical solution) 9,566,290
Flatwing Pharms., LLC v. Anacor Pharms., Inc., IPR2018-00171 (PTAB) Nov. 21, 2017 N/A Kerydin® (tavaborole topical solution) 9,572,823
Shire Development LLC v. Teva Pharms. USA, Inc., 17-1696 (D. Del.) Nov. 22, 2017 Hon. Richard G. Andrews Mydayis® (amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate extended-release capsules)
6,913,768
8,846,100
9,173,857
Onyx Therapeutics, Inc. v. Aurobindo Pharma USA, Inc., 17-1699 (D. Del.) Nov. 22, 2017 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection)
7,417,042
7,232,818
7,491,704
7,737,112
8,129,346
8,207,125
8,207,126
8,207,127
8,207,297
Mitsubishi Tanabe Pharma Corp. v. Aurobindo Pharma USA Inc., 17-12082 (D.N.J.) Nov. 27, 2017 Hon. Freda L. Wolfson Invokana® (canagliflozin tablets)
7,943,788
8,222,219
Forest Labs., LLC v. Mylan Pharms. Inc., 17-1728 (D. Del.) Nov. 30, 2017 Hon. Richard G. Andrews Linzess® (linaclotide capsules) 9,708,371
ViiV Healthcare Co. v. Dr. Reddy's Labs., Inc., 17-1737 (D. Del.) Dec. 1, 2017 Vacant Judgeship (2017) Tivicay® (dolutegravir tablets) 9,242,986
ViiV Healthcare Co. v. Dr. Reddy's Labs., Inc., 17-12374 (D.N.J.) Dec. 1, 2017 Hon. Brian R. Martinotti Tivicay® (dolutegravir tablets) 9,242,986
ViiV Healthcare Co. v. Cipla Ltd., 17-1741 (D. Del.) Dec. 4, 2017 Vacant Judgeship (2017) Tivicay® (dolutegravir tablets) 9,242,986
Mylan Technologies, Inc. v. Noven Pharms., Inc., IPR2018-00173 (PTAB) Dec. 4, 2017 N/A Minivelle® (estradiol extended-release film) 9,724,310
Mylan Technologies, Inc. v. Noven Pharms., Inc., IPR2018-00174 (PTAB) Dec. 4, 2017 N/A Minivelle® (estradiol extended-release film) 9,730,900
Mylan Pharms. Inc. v. Pozen Inc., IPR2018-00272 (PTAB) Dec. 4, 2017 N/A Vimovo® (esomeprazole magnesium / naproxen delayed-release tablets) 9,393,208
Leo Pharma A/S v. Actavis Labs. UT, Inc., 17-1752 (D. Del.) Dec. 6, 2017 Hon. Joseph F. Bataillon Picato® (ingenol mebutate gel)
9,820,959
9,833,428
9,833,429
Leo Pharma A/S v. Perrigo UK Finco Ltd., 17-1753 (D. Del.) Dec. 6, 2017 Hon. Joseph F. Bataillon Picato® (ingenol mebutate gel)
9,820,959
9,833,428
9,833,429
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. v. Gilead Pharmasset LLC, IPR2018-00211 (PTAB) Dec. 6, 2017 N/A Harvoni® (ledipasvir / sofosbuvir tablets) 9,393,256
Chiesi U.S.A., Inc. v. Teva Pharms. USA, Inc., 17-1772 (D. Del.) Dec. 7, 2017 Vacant Judgeship (2017) Bethkis® (tobramycin injection solution)
6,987,094
7,696,178
7,939,502
Pfizer Inc. v. Aurobindo Pharma USA Inc., 17-1775 (D. Del.) Dec. 8, 2017 Hon. Leonard P. Stark Tikosyn® (dofetilide capsules) 6,124,363
Noven Pharms., Inc. v. Mylan Technologies Inc., 17-1777 (D. Del.) Dec. 8, 2017 Hon. Leonard P. Stark Minivelle® (estradiol extended-release film)
9,730,900
9,724,310
Valeant Pharms. Int'l, Inc. v. Actavis Labs. FL, Inc., 17-12857 (D.N.J.) Dec. 8, 2017 Hon. Stanley R. Chesler Relistor® (methylnaltrexone bromide tablets)
9,724,343
9,492,445
Merck Sharp & Dohme Corp. v. Teva Pharms. USA, Inc., 17-6921 (D.N.J.) Sept. 8, 2017 Hon. Michael A. Shipp Entereg® (alvimopan capsules)
6,469,030
8,946,262
ViiV Healthcare Co. v. Sandoz Inc., 17-1784 (D. Del.) Dec. 11, 2017 Vacant Judgeship (2017) Tivicay® (dolutegravir tablets) 9,242,986
ViiV Healthcare Co. v. Sandoz Inc., 17-12912 (D. Del.) Dec. 11, 2017 Hon. Brian R. Martinotti Tivicay® (dolutegravir tablets) 9,242,986
KVK-Tech, Inc. v. Shire PLC, IPR2018-00290 (PTAB) Dec. 11, 2017 N/A Mydayis® (amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate extended-release capsules) 8,846,100
KVK-Tech, Inc. v. Shire PLC, IPR2018-00293 (PTAB) Dec. 11, 2017 N/A Mydayis® (amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate extended-release capsules) 9,173,857
Teva Pharms. Int'l GMBH v. Mylan Labs. Ltd., 17-1790 (D. Del.) Dec. 12, 2017 Hon. Gregory M. Sleet Bendeka® (bendamustine HCl for injection)
8,791,270
8,609,707
9,265,831
9,572,796
9,572,797
9,034,908
9,144,568
9,572,887
9,597,397
9,597,398
9,597,399
9,000,021
9,579,384
Neos Therapeutics, Inc. v. Teva Pharms. USA, Inc., 17-1793 (D. Del.) Dec. 13, 2017 Hon. Gregory M. Sleet Cotempla XR-ODT® (methylphenidate extended-release orally disintegrating tablets)
8,840,924
9,072,680
9,089,496
AstraZeneca Pharms. LP v. Fresenius Kabi USA, LLC, 17-1795 (D. Del.) Dec. 14, 2017 Vacant Judgeship (2017) Faslodex® (fulvestrant for injection)
6,774,122
7,456,160
8,329,680
8,466,139
AstraZeneca Pharms. LP v. Fresenius Kabi USA, LLC, 17-13075 (D.N.J.) Dec. 14, 2017 Hon. Renee Marie Bumb Faslodex® (fulvestrant for injection)
6,774,122
7,456,160
8,329,680
8,466,139
Amgen Inc. v. Watson Labs., Inc., 17-1807 (D. Del.) Dec. 15, 2017 Hon. Gregory M. Sleet Sensipar® (cinacalcet HCl tablets) 9,375,405
Amgen Inc. v. Barr Labs., Inc., 17-1808 (D. Del.) Dec. 15, 2017 Hon. Gregory M. Sleet Sensipar® (cinacalcet HCl tablets) 9,375,405
Amgen Inc. v. Teva Pharms. USA, Inc., 17-1809 (D. Del.) Dec. 15, 2017 Hon. Gregory M. Sleet Sensipar® (cinacalcet HCl tablets) 9,375,405
Mitsubishi Tanabe Pharma Corp. v. Macleods Pharms., Ltd., 17-13130 (D.N.J.) Dec. 15, 2017 Hon. Peter G. Sheridan Invokana® (canagliflozin tablets)
7,943,582
8,513,202
Bracco Diagnostics Inc. v. Maia Pharms., Inc., 17-13151 (D.N.J.) Dec. 15, 2017 Hon. Peter G. Sheridan Kinevac® (sincalide for injection) 6,803,046
Arbor Pharms., LLC v. Taro Pharms. U.S.A., Inc., 17-9846 (S.D.N.Y.) Dec. 15, 2017 Hon. Sidney H. Stein Sklice® (ivermectin lotion)
8,791,153
8,927,595
Gilead Sciences, Inc. v. Mylan Pharms. Inc., 17-0217 (N.D.W.V.) Dec. 15, 2017 Hon. Irene M. Keeley Evotaz® (atazanavir / cobicistat tablets) 8,148,374
Onyx Therapeutics, Inc. v. Dr. Reddy's Labs., Inc., 17-1811 (D. Del.) Dec. 18, 2017 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection)
7,417,042
7,232,818
7,491,704
8,129,346
8,207,125
8,207,126
8,207,127
8,207,297
Eli Lilly and Co. v. Unichem Labs. Ltd., 17-13312 (D.N.J.) Dec. 19, 2017 Katharine S. Hayden Cialis® (tadalafil tablets) 6,943,166
Millennium Pharms., Inc. v. Qilu Pharm. Co., Ltd., 17-1830 (D. Del.) December 20, 2017 Hon. Gregory M. Sleet Velcade® (bortezomib for injection)
6,713,446
6,958,319
CyDex Pharms., Inc. v. Teva Pharms. USA, Inc., 17-1832 (D. Del.) Dec. 20, 2017 Hon. Leonard P. Stark Evomela® (melphalan HCl for Injection)
8,410,077
9,200,088
9,493,582
Onyx Therapeutics, Inc. v. MSN Pharms., Inc., 17-1833 (D. Del.) Dec. 20, 2017 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,737,112
Shire Development LLC v. Rhodes Pharms. L.P., 17-1840 (D. Del.) Dec. 21, 2017 Hon. Richard G. Andrews Adderall XR® (dextroamphetamine saccharate / amphetamine aspartate / dextroamphetamine sulfate / amphetamine sulfate extended-release capsules)
RE41,148
RE42,096
Impax Labs., Inc. v. Zydus Pharms. USA, Inc., 17-13476 (D.N.J.) Dec. 21, 2017 Hon. Stanley R. Chesler Rytary® (levodopa / carbidopa capsules) 9,089,608
Amgen Inc. v. Torrent Pharms. Ltd., 17-1844 (D. Del.) Dec. 22, 2017 Hon. Gregory M. Sleet Sensipar® (cinacalcet HCl tablets) 9,375,405
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. v. Gilead Pharmasset LLC, IPR2018-00390 (PTAB) Dec. 26, 2017 N/A Sovaldi® (sofosbuvir tablets)XXHarvoni® (ledipasvir / sofosbuvir tablets)XXEpclusa® (sofosbuvir / velpatasvir tablets)XXVosevi® (sofosbuvir / velpatasvir / voxilaprevir tablets) 8,889,159
Glaxo Group Ltd. v. Aurobindo Pharma USA, Inc., 17-1862 (D. Del.) Dec. 27, 2017 Vacant Judgeship (2017) Lamictal XR® (lamotrigine extended-release tablets)
8,637,512
9,144,547
Osi Pharms., LLC v. Accord Healthcare Inc., USA, 17-1868 (D. Del.) Dec. 28, 2017 Hon. Gregory M. Sleet Tarceva® (erlotinib HCl tablets) 6,900,221
Mallinckrodt IP Unlimited Co. v. Aurobindo Pharma USA, Inc., 17-1877 (D. Del.) Dec. 29, 2017 Hon. Leonard P. Stark Ofirmev® (acetaminophen for injection)
6,992,218
9,399,012
9,610,265
Patheon Softgels Inc. v. Apotex Inc., 17-13819 (D.N.J.) Dec. 29, 2017 Hon. Michael A. Shipp naproxen sodium OTC Capsules
9,693,978
9,693,979

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.